Merck Exec Joins Novavax; Will Oversee Estrasorb Manufacturing
This article was originally published in The Pink Sheet Daily
Executive Summary
Rahul Singhvi will be responsible for the company’s Philadelphia facility where Estrasorb will be manufactured. The topical estrogen emulsion is expected to launch by June.
You may also be interested in...
Novavax CEO Rahul Singhvi – An Interview With “The Pink Sheet” DAILY, Part 2 of 3
Novavax execs describe the firm's Virus Like Particle technology and how disposable, egg-less virus manufacturing is changing the industry.
Able Unable To Reform On Its Own? Firm Seeks Consent Decree To Address Manufacturing Issues
“We are prepared to enter discussions toward a decree at FDA’s earliest convenience,” Able says in letter to FDA. Company is pursuing consent decree instead of responding to FDA Form 483 report citing manufacturing deficiencies. The letter follows CEO Maury’s resignation the previous day.